Determinants of blood pressure treatment and control in obese people: evidence fromthe general population

Journal of Hypertension

Volumn 30, Issue 12, 2012, Pages 2338-2344

  Czernichow, Sébastien ^a,b   Castetbon, Katia ^c,d   Salanave, Benoit ^c,d   Vernay, Michel ^c,d   Barry, Yaya ^c,d,e   Batty, George D ^f   Hercberg, Serge ^c,d,e   Blacher, Jacques ^e,f,g,h  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d UNIVERSITÉ PARIS 13   (France)

^e Research Department of Epidemiology and Public Health ^*  (France)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h HÔPITAL AMBROISE PARÉ   (France)

Author keywords

blood pressure control; hypertension; obesity; population based study

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FRANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84870248556     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283593010     Document Type: Article

References (23)

1. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011; 377/9765:568-577.
2. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377/9765:557-567.
3. Haslam DW, James WP. Obesity. Lancet 2005; 366/9492:1197-1209.
4. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295/13:1549-1555.
5. Castetbon K, Vernay M, Malon A, Salanave B, Deschamps V, Roudier C, et al. Dietary intake, physical activity and nutritional status in adults: the French nutrition and health survey (ENNS, 2006-2007). Br J Nutr 2009; 102/5:733-743.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42/6:1206-1252.
7. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007; 25/9:1751-1762.
8. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282/16:1523-1529.
9. Jordan J, Engeli S, Redon J, Sharma AM, Luft FC, Narkiewicz K, et al. European Society of Hypertension Working Group on Obesity: background, aims and perspectives. J Hypertens 2007; 25/4:897-900.
10. Roux O, Chapellier M, Czernichow S, Nisse-Durgeat S, Safar ME, Blacher J. Determinants of hypertension control in a large French population of treated hypertensive subjects. Blood Press 2006; 15/1: 6-13.
11. Czernichow S, Ninomiya T, Huxley R, Kengne AP, Batty GD, Grobbee DE, et al. Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial. Hypertension 2010; 55/5:1193-1198.
12. Godet-Mardirossian H, Girerd x, Vernay M, Chamontin B, castetbon K, de PC. Patterns of hypertension management in France (ENNS 2006-2007). Eur J Cardiovasc Prev Rehabil 2011; 19:213-220.
13. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on Obesity. WHO Technical Report Series no. 894. Geneva, Switzerland: WHO; 2000.
14. IPAQ group, 2005. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ) 2012 http://www. ipaq.ki.se/scoring.pdf. [Accessed 15 November 2011]
15. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med (Berl) 2001; 79/1:21-29.
16. Reisin E, Jack AV. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am 2009; 93/3:733-751.
17. Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, et al. Factors associated with hypertension awareness, treatment, and control in a representative sample of the chinese population. Hypertension 2004; 43/3:578-585.
18. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303/20:2043-2050.
19. Wagner A, Sadoun A, Dallongeville J, Ferrieres J, Amouyel P, Ruidavets JB, et al. High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens 2011; 29/1:43-50.
20. Qvarnstrom M, Wettermark B, Ljungman C, Zarrinkoub R, Hasselstrom J, Manhem K, et al. Antihypertensive treatment and control in a large primary care population of 21 167 patients. J Hum Hypertens 2011; 25/8:484-491.
21. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355/9205:675-687.
22. Cottel D, Dallongeville J, Wagner A, Ruidavets JB, Arveiler D, Ferrieres J, et al. The North-East-South gradient of coronary heart disease mortality and case fatality rates in France is consistent with a similar gradient in risk factor clusters. Eur J Epidemiol 2000; 16/4:317-322.
23. Vernay M, Malon A, Oleko A, Salanave B, Roudier C, Szego E, et al. Association of socioeconomic status with overall overweight and central obesity in men and women: the French Nutrition and Health Survey 2006. BMC Public Health 2009; 9:215.